News

LIVE WEBINAR 27/02 | Setting up a cyclotron radiopharmacy: Navigating the challenges through two case studies
Live Webinar on February 27th with Dr Richard Freifelder Setting up a cyclotron radiopharmacy: Navigating the challenges through two case […]
See more
iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70
Successful completion of contractual site acceptance tests, with 70 MeV cyclotron now fully operational Louvain-la-Neuve, Belgium, January 23, 2024 – […]
See more
IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron
Wednesday, December 20th, 2023 Louvain-la-Neuve, Belgium, December 20, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in […]
See more
WEBINAR | Will the approval of one or more AD drug unleash the use of amyloid PET imaging?
Listen the webinar on demand and be part of the forefront of PET imaging in Alzheimer's disease This interesting webinar […]
See more
Successful rigging of IBA's Cyclone® 30XP at POLATOM, Poland
We are happy to announce the successful rigging of our Cyclone® 30XP cyclotron at POLATOM that marks a significant milestone […]
See more
IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
Wednesday, December 13rd, 2023 Louvain-la-Neuve, Belgium, December 13, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), CMI Inc. and Life […]
See more
IBA pioneers theranostic advancements, empowering the market to produce Astatine-211
Tuesday, December 12th, 2023 Rigging of the Cyclone® 30XP in Poland completed with a further two sites in Germany and […]
See more
Successful rigging of IBA's Cyclone Kiube at SIAT, China
Celebrating a significant achievement with the successful rigging of IBA's Cyclone® Kiube at Shenzen Institute of Advanced Technology, Chinese Academy […]
See more
Register for the learn & Talk session at SNMMI
Discover IBA's Learn and Talk sessions at SNMMI: Advantages and Disadvantages of 225Ac-PSMA therapy in Prostate Cancer Patients Prof. Sathkege […]
See more